| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $119.57 | $23.48 | 409.24% | 225.60x | 56.91x | 15.17x | 18.31x | 1.63x | $106.92M | 0.85% | $705.78M | 6.70 | $12.82B | 1,634.63 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.92 | $8.02 | 198.19% | 113.90x | 53.48x | 6.73x | 13.63x | 0.98x | $39.15M | 1.25% | $220.58M | 1.69 | $3.09B | 67.99 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $223.94 | $78.59 | 184.94% | 36.71x | 33.21x | 6.23x | 22.13x | 1.27x | $793.95M | 2.65% | $1.35B | 10.14 | $31.24B | 26.49 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $77.09 | $16.92 | 355.72% | 72.05x | 65.95x | 7.11x | 9.19x | 1.84x | $182.84M | 3.06% | $654.15M | 8.43 | $5.85B | 48.75 | ||
| KRYS | KRYSTAL BIOTECH INC | $326.81 | $82.01 | 298.52% | 39.52x | 41.87x | 21.91x | 7.12x | 2.11x | $257.78M | 2.67% | $1.36B | 46.03 | $9.25B | 39.67 | ||
| VCEL | VERICEL CORP | $40.05 | $7.81 | 412.90% | 83.44x | 71.56x | 6.68x | 5.54x | 2.05x | $61.66M | 3.01% | $370.04M | 7.25 | $2.02B | 45.81 | ||
| HALO | HALOZYME THERAPEUTICS INC | $109.72 | $69.50 | 57.87% | 30.82x | 12.15x | 7.73x | 86.75x | 0.59x | $806.22M | 6.27% | $143.54M | 1.22 | $14.44B | 20.09 | ||
| RPRX | ROYALTY PHARMA PLC | $56.44 | $35.34 | 59.72% | 30.02x | 10.32x | 9.91x | 3.32x | 0.61x | $2.92B | 11.64% | $9.79B | 21.99 | $40.60B | 34.52 | ||
| TGTX | TG THERAPEUTICS INC | $52.19 | $21.90 | 138.34% | 16.94x | 52.52x | 9.25x | 13.22x | 1.89x | $17.39M | 0.24% | $604.08M | 4.26 | $8.26B | 59.31 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.22 | $18.20 | 208.89% | 147.95x | 19.43x | 3.19x | 1.72x | 0.98x | $738.18M | 6.79% | $6.32B | 32.68 | $14.19B | 36.80 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.73 | $7.43 | 44.34% | 11.29x | 9.86x | 4.67x | 2.93x | 0.99x | $82.01M | 12.92% | $217.65M | 3.68 | $493.36M | 6.38 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $231.39 | $176.07 | 31.42% | 15.16x | 9.05x | 3.18x | 3.13x | 0.62x | $1.62B | 11.07% | $4.80B | 75.98 | $17.80B | 11.01 | ||
| EXEL | EXELIXIS INC | $58.33 | $29.31 | 99.04% | 17.73x | 17.63x | 6.01x | 7.84x | 1.17x | $1.17B | 8.01% | $1.84B | 7.35 | $14.34B | 13.18 | ||
| MDXG | MIMEDX GROUP INC | $4.62 | $1.24 | 271.53% | 115.50x | -26.64x | 1.92x | 3.12x | 1.25x | $44.50M | 6.52% | $216.00M | 1.46 | $554.78M | 24.32 | ||
| ADMA | ADMA BIOLOGICS INC | $10.18 | $6.82 | 49.37% | 14.14x | 12.80x | 4.53x | 5.59x | 0.82x | $116.47M | 5.01% | $408.21M | 1.79 | $2.34B | 10.05 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $296.94 | $83.85 | 254.12% | 29.49x | 31.43x | 20.51x | 6.12x | 2.23x | $130.62M | 2.19% | $967.52M | 48.22 | $6.04B | 21.67 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $502.31 | $144.91 | 246.63% | 28.98x | 26.24x | 10.12x | 6.29x | 2.18x | $3.80B | 2.98% | $20.25B | 79.81 | $123.15B | 22.38 | ||
| UTHR | UNITED THERAPEUTICS CORP | $541.62 | $184.23 | 193.99% | 17.91x | 20.27x | 7.31x | 3.63x | 3.29x | $1.09B | 4.74% | $6.40B | 150.24 | $21.43B | 12.78 | ||
| TECH | BIO-TECHNE CORP | $72.43 | $15.90 | 355.40% | 61.91x | 34.86x | 9.30x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.38B | 32.74 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.36 | $29.39 | 33.91% | 12.54x | 9.44x | 2.38x | 2.29x | 0.75x | $354.90M | 15.56% | $999.24M | 17.25 | $1.90B | 6.77 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $738.72 | $417.95 | 76.75% | 17.61x | 13.17x | 4.89x | 2.40x | 0.93x | $3.76B | 4.95% | $31.71B | 308.48 | $76.31B | 13.27 | ||
| VCYT | VERACYTE INC | $44.65 | $11.45 | 289.79% | 31.01x | 22.96x | 6.35x | 2.59x | 2.60x | $165.99M | 4.65% | $1.39B | 17.36 | $3.33B | 23.83 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.19 | $1.36 | -12.23% | 8.50x | -2.68x | 1.47x | 1.57x | 0.47x | $19.58M | 28.40% | $44.20M | 0.76 | $20.57M | 2.69 | ||
| INCY | INCYTE CORP | $112.73 | $57.54 | 95.92% | 13.88x | 31.80x | 3.88x | 3.60x | 1.56x | $1.92B | 8.50% | $6.34B | 31.66 | $18.90B | 9.14 |